The findings and conclusions in these presentations have not been formally disseminated by the Centers for Disease Control and Prevention and should not be construed to represent any agency determination or policy.

Wednesday, May 10, 2006
273

Seroprevalence of herpes simplex virus type 1 and type 2 in pregnant women in the United States

Fujie Xu1, Lauri Markowitz2, Sami Gottlieb3, and S. Berman1. (1) Division of STD Prevention, CDC, 1600 Clifton Road, Mailstop E-02, Atlanta, GA, USA, (2) Division of STD Prevention, Epidemiology and Surveillance Branch, Epidemiology and Research Section, CDC, 1600 Clifton Road, NE, MS E-02, Atlanta, GA, USA, (3) 1600 Clifton Road, CDC, Mailstop E-02, Atlanta, GA, USA


Background:
A recent large study in the US suggests that infants born to women seronegative for herpes simplex virus (HSV) infection may be at higher risk for neonatal herpes.

Objective:
To determine seroprevalence of HSV type 1 (HSV-1) and type 2 (HSV-2) in a national sample of pregnant women.

Method:
National Health and Nutrition Examination Survey (NHANES) 1999-2002 is a nationally representative survey of civilian non-institutionalized US population. As part of this survey, serum samples were tested for antibodies to HSV-1 and HSV-2 using type-specific immunodot assays, and pregnancy tests (urine and serum) were performed for female participants 12-59 years of age.

Result:
This analysis included 626 pregnant women. The mean age was 27 years and the median number of lifetime sex partners was 4. Overall, 28% of pregnant women were seronegative, 63% seropositive for HSV-1, and 22% seropositive for HSV-2. HSV seroprevalence differed by race-ethnicity, with non-Hispanic whites more likely to be seronegative compared with other racial-ethnic groups (40% versus 11%, P<0.001). The number of lifetime sex partners was also associated with serostatus: 39% of those with 1-2 partners were seronegative, compared with 20% of those with >=3 partners. Based on serostatus-specific neonatal herpes rates from the literature and the serostatus distribution in NHANES 1999-2002, the rate of neonatal herpes is projected to be 33/100,000 live births in the US, corresponding to 1,300 cases per year. The projected rate is 40% higher in non-Hispanic whites than in other racial-ethnic groups.

Conclusion:
The seroprevalence of HSV-1 and HSV-2 is high in pregnant women in the US. Babies born to non-Hispanic white mothers appear to be at greater risk for neonatal herpes.

Implications:
Efforts to prevent neonatal herpes should include populations traditionally regarded as low risk for HSV infection.